Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Charlottesville, VA
NPI: 1073779476Primary Practice Location
UNIVERSITY OF VIRGINIA MEDICAL CENTER
1215 Lee St, Charlottesville, VA
Primary Employer
UVA Physicians Group
virginia.edu
HQ Phone
Get M.D. Binit's Phone Numberphone_androidMobile
Get M.D. Binit's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 172 | 230 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 77 | 93 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 63 | 67 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 59 | 59 |
| 5 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 30 | 87 |
Authors: W. Jeffrey Elias, Robert Dallapiazza
Journal: Stereotact Funct Neurosurg
Publication Date: 2018-02-12
A pilot study of focused ultrasound thalamotomy for essential tremor.
Authors: Madaline Harrison, W. Jeffrey Elias
Publication Date: 2013-08-16
Lead Sponsor: University of Rochester
Collaborators: Biogen, Takeda
Lead Sponsor: Northwestern University
Collaborators: Michael J. Fox Foundation for Parkinson's Research, University of Rochester, University of Iowa
Intervention / Treatment: DRUG: Placebo, DRUG: Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), DRUG: Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)
Lead Sponsor: NeuroDerm Ltd.
Intervention / Treatment: COMBINATION_PRODUCT: Placebo for SC infusion, DRUG: Placebo for Oral IR-LD/CD, COMBINATION_PRODUCT: ND0612 Solution for SC infusion, DRUG: Oral IR-LD/CD
